StockGlow

Incyte Corporation (ICY.F)

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

110.35-0.04%Healthcare
Compare ICY.F with
StockGlow Score
93
Bullish
BearishBullish
1 year ago+69.7%

The outlook

Incyte Corporation currently reads as bullish based on above its 50- & 200-day averages, 90% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range90% of the way from its 52-week low to high
Market cap
$22.37B
52-wk high
115.40
52-wk low
65.02
50-day avg
93.72
200-day avg
86.94
Trailing P/E
16.0

Similar stocks

VX1.FVertex Pharmaceuticals Incorporated$411.25-4.09%ILU.FIllumina, Inc.$168.84-1.15%DUL.FAlnylam Pharmaceuticals, Inc.$178.20-28.66%BM8.FBioMarin Pharmaceutical Inc.$53.70-1.03%RGO.FRegeneron Pharmaceuticals, Inc.$616.00+0.49%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy